作者
Fei Liu,Qinglong Jin,Y X Zhang,Guozhong Gong,Guo-Qiang Wu,Lufeng Yao,Xiao-Chun Wen,Zhiliang Gao,Yuzhou Huang,Daoke Yang,E Q Chen,Qiang Mao,Shudian Lin,Jing Shang,Hongyu Gong,Lintao Zhong,Heng Yin,F M Wang,Pin Jin Hu,Xia Zhang,Qun Gao,Chengqiang Jin,Cuiling Li,Junqi Niu,Jinlin Hou
摘要
In chronic hepatitis B (CHB) patients with previous 96-week treatment with tenofovir amibufenamide (TMF) or tenofovir disoproxil fumarate (TDF), we investigated the efficacy of sequential TMF treatment from 96 to 144 weeks.